Basel, Switzerland

Oskar Wacker


Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 118(Granted Patents)


Location History:

  • Basle, CH (1993 - 1995)
  • Basel, CH (1979 - 1998)

Company Filing History:


Years Active: 1979-1998

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Oskar Wacker

Introduction

Oskar Wacker, a prominent inventor based in Basel, Switzerland, has made significant strides in the realm of chemistry and pharmaceutical science. With a portfolio of 13 patents, Wacker's work reflects a commitment to tackling complex challenges in drug development and resistance.

Latest Patents

Wacker's recent innovations include a series of patents aimed at combating multi-drug resistance. Notable patents include "Carbazole derivatives as agents against multi-drug resistance," "Polycyclic compounds and processes for the preparation thereof," and "N-(tetrahydropyran-4-yloxy-alkanoyl)-staurosporin derivatives of formula I," wherein R1 is defined as hydrogen, hydroxy, lower alkoxy, or oxo. These contributions represent a progressive step in the search for effective treatments in pharmacology.

Career Highlights

Wacker's impressive career has seen him collaborate with notable organizations such as Ciba-Geigy Corporation and Novartis Corporation. His tenure at these companies has allowed him to hone his skills and contribute to groundbreaking research, particularly in medicinal chemistry and compound development.

Collaborations

Throughout his professional journey, Wacker has worked alongside distinguished colleagues, including Gerhard Baschang and Albert Hartmann. These collaborations have fostered an environment of creativity and shared expertise, enriching the innovation landscape in which Wacker operates.

Conclusion

Oskar Wacker's contributions to science and innovation are marked by his inventive spirit and dedication to addressing critical challenges in medicine. His patents not only reflect his individual efforts but also highlight the power of collaboration in driving progress within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…